July 9, 2020 by Chain Drug Review
COVID-19, Stefano Pessina, Walgreens, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) said on Thursday its financial results for the fiscal 2020 third quarter, which ended May 31, were significantly impacted by the COVID-19 pandemic. “Prior to the pandemic our financial performance for fiscal 2020 was on track with our expectations. However, this unprecedented global crisis led to a loss
July 8, 2020 by Chain Drug Review
Stefano Pessina, Tim Barry, VillageMD, Walgreens
Featured Articles, Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. – Walgreens Boots Alliance (WBA) and VillageMD announced Wednesday that Walgreens will be the first national pharmacy chain to offer full-service doctor offices co-located at its stores at a large scale, following a highly successful trial begun last year. This expanded partnership will open 500 to 700 “Village Medical at Walgreens” physician-led primary care clinics
June 1, 2020 by Chain Drug Review
George Floyd, Stefano Pessina, Walgreens
Leading Headlines, Retail News
Stefano Pessina, executive vice chairman and chief executive officer of Walgreens Boots Alliance has issued the following statement to customers, store team members and communities across America on the killing of George Floyd and protests that followed: “On behalf of everyone at Walgreens Boots Alliance, we share the sadness and sense of injustice felt by
April 2, 2020 by Chain Drug Review
Stefano Pessina, Walgreens, WBA
Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. posted better than expected second quarter sales and earnings Thursday. The company’s adjusted earnings per share of $1.52 topped Wall Street’s forecast of $1.46. Sales of $35.82 billion beat the projection of $35.27 billion. The quarter ended February 29, before the number of COVID-19 cases in the U.S. swelled
January 8, 2020 by Chain Drug Review
Stefano Pessina, Walgreens, WBA
Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance’s first quarter results fell short of Wall Street’s forecast. Adjusted earnings per share for the period ended November 30 were $1.37, while analysts had projected $1.41. Adjusted net earnings slid 11.8% to $1.2 billion, down 11.6% on a constant currency basis, from the year-ago period. Revenue also missed expectations,
November 13, 2019 by Chain Drug Review
American-Italian Cancer Foundation (AICF), Claudio Del Vecchio, Daniele Bodini, Stefano Pessina
Leading Headlines, Retail News
NEW YORK – On Tuesday night, the American-Italian Cancer Foundation (AICF) presented Stefano Pessina, executive vice chairman and chief executive officer of Walgreens Boots Alliance (WBA) with the Alessandro di Montezemolo Lifetime Achievement Award for his outstanding career in health care. AICF, a New York nonprofit supporting cancer research and early detection, honored Pessina at
October 17, 2019 by Chain Drug Review
Centene Corp., innovative model for pharmacy management, Michael Neidorff, RxAdvance, Stefano Pessina, Walgreens
Featured Articles, Leading Headlines, Pharmacy
DEERFIELD, Ill. – Centene Corp., Walgreens and RxAdvance announced on Thursday a strategic partnership to introduce an innovative model for pharmacy management that aims to increase transparency, enhance customer experience and ultimately result in better health outcomes at lower costs. The partnership builds upon an existing Centene and Walgreens relationship, leveraging Walgreens trusted retail pharmacy
June 27, 2019 by Chain Drug Review
Stefano Pessina, Walgreens Boots Alliance
Business, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance’s (WBA’s) third quarter profit beat analysts’ expectations, as U.S. pharmacy sales rose 4.3% in the period ended May 31. Net earnings slipped 23.6% to $1 billion compared to the year-ago quarter, while net earnings per share decreased 16.5% to $1.13. Stripping out special items, the company earned $1.47 per
February 4, 2019 by Jeffrey Woldt
Stefano Pessina, Walgreens Boots Alliance (WBA)
February 4, 2019, Opinion
Walgreens Boots Alliance has entered the early stages of a profound transition, one that will see the organization pivot from a store-first to a digital-first model. Any lingering doubts about the direction the company is headed were put to rest earlier this month when WBA unveiled a seven-year agreement with Microsoft to harness the power
January 15, 2019 by Chain Drug Review
Azure cloud and AI technology and Microsoft 365, Microsoft Corp., Satya Nadella, Stefano Pessina, Walgreens Boots Alliance Inc. (WBA)
Featured Articles, Leading Headlines, Pharmacy, Retail News, Technology
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) and Microsoft Corp. have teamed up to develop new health care delivery models, technology and retail innovations to advance and improve the future of health care. The companies will combine the power of Microsoft Azure, Microsoft’s cloud and AI platform, health care investments, and new retail solutions with WBA’s
January 7, 2019 by Chain Drug Review
Stefano Pessina, Verily, Walgreens
January 7, 2019, News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) and Verily, an Alphabet company, will be collaborating on multiple projects under a broad agreement aimed at improving health outcomes for patients with chronic conditions, while also lowering the cost of care. Walgreens will be a first-choice retail pharmacy development and commercialization partner to Verily, and the organizations
December 20, 2018 by Chain Drug Review
FedEx and Humana, Kroger, Stefano Pessina, Walgreens, Walgreens Boots Alliance
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) on Thursday reported first quarter double-digit earnings growth for fiscal 2019 that beat analysts’ expectations, while revenue fell short of forecasts. The retailer’s revenue was $33.79 billion. “We are pleased to have delivered double-digit percentage growth in earnings per share in the first quarter, including solid results in
October 11, 2018 by Chain Drug Review
David King, LabCorp at Walgreens, Stefano Pessina, Walgreens, Walgreens Boots Alliance
Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill. and BURLINGTON, N.C. — Walgreens and LabCorp announced their mutual commitment to a significant expansion of their LabCorp at Walgreens collaboration. The two companies have agreed to open at least 600 LabCorp patient service centers at Walgreens stores across the U.S. over the next four years, inclusive of the 17 locations that have
October 11, 2018 by Chain Drug Review
Stefano Pessina, Walgreens, Walgreens Boots Alliance
Business, Featured Articles
DEERFIELD, Ill. — Walgreens Boots Alliance posted mixed fourth quarter results, as earnings beat expectations but sales fell short of projections. Adjusted net earnings for the quarter ended August 31 rose 4.5% to $1.4 billion, up 4.5% on a constant currency basis, from a year ago. Adjusted earnings per share were $1.48, up 13% on